Literature DB >> 7821124

Effect of endogenous cholecystokinin on postprandial gallbladder refilling. Ultrasonographic study in healthy subjects and in gallstone patients.

M Cicala1, E Corazziari, D Diacinti, D Badiali, A Torsoli.   

Abstract

The postprandial release of cholecystokinin (CCK) regulates gallbladder (GB) contraction but little is known about the role, if any, of the still-elevated CCK blood levels on subsequent GB refilling. To assess the role of CCK in GB refilling, a CCK-receptor antagonist, loxiglumide, or saline were infused intravenously in a random double-blind fashion after the ingestion of a liquid test meal in 16 healthy subjects. An identical study protocol was performed in 10 GB "contractor" patient with radiolucent stones to ascertain whether the reported reduced CCK effect on GB emptying also affects GB refilling. GB volumes were assessed ultrasonographically in the fasting state and for 150 min at 15-min intervals after meal ingestion. GB volumes during postprandial refilling were significantly greater during loxiglumide than placebo infusion (P < 0.01), but they did not differ between gallstone and control subjects. In conclusion, postprandial endogenous CCK has a relevant role in delaying GB refilling, and this effect is not altered in patients with radiolucent gallstones.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7821124     DOI: 10.1007/bf02063946

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution.

Authors:  D Festi; R Frabboni; F Bazzoli; A Sangermano; M Ronchi; L Rossi; P Parini; M Orsini; A M Primerano; G Mazzella
Journal:  Gastroenterology       Date:  1990-12       Impact factor: 22.682

2.  Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans.

Authors:  R Meier; P Hildebrand; M Thumshirn; C Albrecht; B Studer; K Gyr; C Beglinger
Journal:  Gastroenterology       Date:  1990-12       Impact factor: 22.682

3.  A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction.

Authors:  G T Everson; D Z Braverman; M L Johnson; F Kern
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

4.  Role of cholecystokinin in regulation of gastrointestinal motor functions.

Authors:  B M Meyer; B A Werth; C Beglinger; P Hildebrand; J B Jansen; D Zach; L C Rovati; G A Stalder
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

5.  Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.

Authors:  R A Liddle; B J Gertz; S Kanayama; L Beccaria; T W Gettys; I L Taylor; R J Rushakoff; V C Williams; L D Coker
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

6.  The role of neurotensin in human gallbladder motility.

Authors:  J P Walker; T Khalil; I Wiener; C J Fagan; C M Townsend; G H Greeley; J C Thompson
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

7.  Release of radioimmunologic cholecystokinin in human subjects.

Authors:  H D Becker; M Werner; A Schafmayer
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

8.  Effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography. Determination of threshold, dose-response relationships and comparison with intraduodenal bilirubin output.

Authors:  W P Hopman; P J Kerstens; J B Jansen; G Rosenbusch; C B Lamers
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

9.  Abnormal gallbladder emptying in patients with gallstones.

Authors:  R S Fisher; F Stelzer; E Rock; L S Malmud
Journal:  Dig Dis Sci       Date:  1982-11       Impact factor: 3.199

10.  Plasma cholecystokinin and gallbladder responses to intraduodenal fat in gallstone patients.

Authors:  A A Masclee; J B Jansen; W M Driessen; L M Geuskens; C B Lamers
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.